Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease

Background Soluble CD36 (sCD36) clusters with insulin resistance, but no evidence exists on its relationship with hepatic fat content. We determined sCD36 to assess its link to steatosis in nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis C (CHC) patients. Materials and methods Two hun...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical investigation 2014-01, Vol.44 (1), p.65-73
Hauptverfasser:	García-Monzón, Carmelo, Lo Iacono, Oreste, Crespo, Javier, Romero-Gómez, Manuel, García-Samaniego, Javier, Fernández-Bermejo, Miguel, Domínguez-Díez, Agustín, Rodríguez de Cía, Javier, Sáez, Alicia, Porrero, José Luís, Vargas-Castrillón, Javier, Chávez-Jiménez, Enrique, Soto-Fernández, Susana, Díaz, Ainhoa, Gallego-Durán, Rocío, Madejón, Antonio, Miquilena-Colina, María Eugenia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Case-Control Studies CD36 Antigens - blood Fatty acid translocase Fatty Liver - blood Fatty Liver - pathology Female Hepatitis C, Chronic - blood Hepatitis C, Chronic - pathology Humans Liver - pathology Male Middle Aged Non-alcoholic Fatty Liver Disease nonalcoholic fatty liver disease noninvasive diagnosis Risk Factors serum biomarker Severity of Illness Index steatosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!